*Liu Y, Cao J, Zhu YN, Ma Y, Murtaza G, Li Y, Wang JH, Pu YS: C1222C deletion in exon 8 of ABL1 is involved in carcinogenesis and cell cycle control of colorectal cancer through IRS1/PI3K/Akt pathway. Front Oncol. 2020 Aug 11;10:1385., URL: https://pubmed.ncbi.nlm.nih.gov/32850446/, *Tarantelli C, Cannas E, Ekeh H, Moscatello C, Gaudio E, Cascione L, Napoli S, Rech C, Testa A, Maniaci C, Rinaldi A, Zucca E, Stathis A, Ciulli A, Bertoni F: The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type. Explor Target Antitumor Ther. 2021;2 (6) :586-601., URL: https://pubmed.ncbi.nlm.nih.gov/36046113/, *Arkhypov I, Özbay Kurt FG, Bitsch R, Novak D, Petrova V, Lasser S, Hielscher T, Groth C, Lepper A, Hu X, Li W, Utikal J, Altevogt P, Umansky V: HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling. J Immunother Cancer. 2022 Sep;10 (9) :e005551. , URL: https://pubmed.ncbi.nlm.nih.gov/36113897/, *Veggiani G, Villaseñor R, Martyn GD, Tang JQ, Krone MW, Gu J, Chen C, Waters ML, Pearce KH, Baubec T, Sidhu SS: High-affinity chromodomains engineered for improved detection of histone methylation and enhanced CRISPR-based gene repression. Nat Commun. 2022 Nov 30;13 (1) :7381., URL: https://pubmed.ncbi.nlm.nih.gov/36450737/, *Liu CC, Leclair P, Pedari F, Vieira H, Monajemi M, Sly LM, Reid GS, Lim CJ: Integrins and ERp57 coordinate to regulate cell surface calreticulin in immunogenic cell death. Front Oncol. 2019 May 28;9:411., URL: https://pubmed.ncbi.nlm.nih.gov/31192123/, *Fonseka CL, Hardman CS, Woo J, Singh R, Nahler J, Yang J, Chen YL, Kamaladasa A, Silva T, Salimi M, Gray N, Dong T, Malavige GN, Ogg GS: Dengue virus co-opts innate type 2 pathways to escape early control of viral replication. Commun Biol. 2022 Jul 22;5 (1) :735., URL: https://pubmed.ncbi.nlm.nih.gov/35869167/, *Hartwig J, Loebel M, Steiner S, Bauer S, Karadeniz Z, Roeger C, Skurk C, Scheibenbogen C, Sotzny F: Metformin attenuates ROS via FOXO3 activation in immune cells. Front Immunol. 2021 Apr 19;12:581799., URL: https://pubmed.ncbi.nlm.nih.gov/33953705/, *Triguero-Martínez A, Roy-Vallejo E, Montes N, de la Fuente H, Ortiz AM, Castañeda S, González-Álvaro I, Lamana A: Genetic LGALS1 variants are associated with heterogeneity in galectin-1 serum levels in patients with early arthritis. Int J Mol Sci. 2022 Jun 28;23 (13) :7181. , URL: https://pubmed.ncbi.nlm.nih.gov/35806182/